Research Applications

 
Stock Quotes for Research Applications top ^
  • Industry: Software - Application
  • Sector: Technology
  • Stock Style: Small Value
Sign-up for 526443 investment picks
  • Industry: Communication Equipment
  • Sector: Technology
  • Stock Style: Small Value
Sign-up for 060540 investment picks

 
News Articles for Research Applications top ^
Accenture (NYSE:ACN) has been named a “Leader” in Gartner Inc.’s recently published “Magic Quadrant for SAP Application Management Service Providers, Worldwide.
Sign-up for Accenture Positioned the Furthest within “Leaders” Quadrant of Gartner’s Magic Quadrant for Worldwide SAP Application Management Service Providers, Worldwide investment picks
2014/11/4
http://media.marketwire.com/attachments/201411/TN-288094_1_WDAY_InsightApps_RetentionRisk.jpg Workday Insight Applications will address specific business scenarios, such as employee retention risk, by providing insights, surfacing predictions, and recommending actions that a decision-maker can take.
Sign-up for Workday Unveils Insight Applications investment picks
Riverbed Technology (NASDAQ:RVBD), the leader in application performance infrastructure, today announced another product from the Riverbed Application Performance Platform TM is now Microsoft Azure Certified.
Sign-up for Riverbed Delivers New Microsoft Azure Certified Solution to Improve Application Performance, Reduce Costs and Increase Productivity Across the Hybrid Enterprise investment picks
Riverbed Technology (NASDAQ:RVBD), the leader in application performance infrastructure, today introduced the most powerful Riverbed® SteelHead™ appliances to date.
Sign-up for Riverbed Introduces the Most Powerful SteelHead Appliance for Application Optimization, Visibility and Control Across the Hybrid Enterprise investment picks
2014/11/10
CA WORLD ’14 — CA Technologies (NASDAQ:CA) CEO Mike Gregoire kicked off CA World ’14 with a keynote address to thousands of customers and partners from around the world.
Sign-up for CA World 2014: CA Technologies CEO Challenges Business and Technology Leaders to Build New Capabilities to Compete in the Application Economy investment picks
Dealertrack Technologies (Nasdaq:TRAK) today announced that the number of active lenders connected to the Dealertrack Credit Application Network has surpassed 1,500 lenders.
Sign-up for Dealertrack Credit Application Network Now Connects More Than 1,500 Lenders investment picks
Riverbed Technology (NASDAQ:RVBD), the leader in application performance infrastructure, is pleased to announce that the winner of the 2014 Riverbed ® SteelScript ™ Ideas Contest is Lionel Marie, network architect at Schneider Electric, a 176-year-old French firm that specializes in energy management.
Sign-up for Riverbed Recognizes Schneider Electric for Most Innovative Use of SteelScript Open APIs to Customize Riverbed Application Performance Platform investment picks
Riverbed Technology (NASDAQ: RVBD), the leader in application performance infrastructure, today at Riverbed FORCE 2014 announced the next-generation of two Riverbed flagship products – Riverbed® SteelHead™ 9.0 and Riverbed® SteelCentral™ AppResponse 9.5 – to deliver the most complete visibility, control, and optimization solution to accelerate performance of on-premises, cloud, and SaaS applications.
Sign-up for Riverbed Announces the Most Complete Visibility and Control Solution to Optimize Performance of Any Application Across the Hybrid Enterprise investment picks
Akamai-sponsored Study Highlights Cloud Adoption Strategies, Current BYOD Demands CAMBRIDGE, Mass.
Sign-up for 43 Percent of Enterprise Decision-makers Plan to Run Majority of Business Applications over the Internet in 2015 investment picks
Splunk Inc. (NASDAQ: SPLK), provider of the leading software platform for real-time Operational Intelligence, today announced that Splunk® Enterprise has been named Best Business Application at the fifth annual V3 Technology Awards .
Sign-up for Splunk Enterprise Voted Best Business Application by V3 Readers investment picks
2014/11/11
CA WORLD — Today winners of CA Technologies (NASDAQ:CA) 2014 VIP Customer Awards were announced at CA World ‘14. The awards recognize customers that have achieved new levels of success using CA solutions in new and innovative ways to help meet the dynamic business needs of businesses in today’s application economy.
Sign-up for CA Technologies 2014 VIP Customer Awards Highlight Success and Innovation in Today’s Application Economy investment picks
Accenture (NYSE:ACN) has been positioned furthest for completeness of vision and highest for ability to execute in the "Leaders" quadrant in the recent report from Gartner Inc., “Magic Quadrant for Oracle Application Management Service Providers, Worldwide 1 .” Gartner assessed 14 service providers for this report.
Sign-up for Accenture Positioned Highest in the "Leaders" Quadrant of Gartner's Magic Quadrant for Oracle Application Management Service Providers Worldwide investment picks
New Platform Provides Advanced Security for Applications and Secure Remote Access for U.S. Government Agencies CAMPBELL, Calif.
Sign-up for Barracuda Web Application Firewall and Barracuda NG Firewall Now Available in the Microsoft Azure Government Image Gallery investment picks
DIGIPASS for Apps and DIGIPASS for Mobile Bring Risk Scoring and Secure Application-to-Application Communications to Safeguard Mobile Applications and Transactions from the Latest Attacks PARIS and LAS VEGAS , Nov.
Sign-up for VASCO Unveils New Security Modules for Application Developers and ISVs investment picks
The German Federal Institute for Drugs and Medical Devices ("BfArM") has validated the European Marketing Authorization Application submitted for RIZAPORT™ and initiated its formal review of the application on November 25, 2014 IntelGenx and RedHill continue to work with the FDA to resolve the remaining Chemistry, Manufacturing and Controls ("CMC") issues and secure a compliant source of the raw material, in order to advance potential FDA approval of the U.S. New Drug Application submitted by the companies RIZAPORT™ oral thin film formulation of rizatriptan for acute migraines presents an attractive therapeutic alternative for many migraine patients, including those suffering from migraine-related nausea, due to its convenient dosing, lack of need for water intake and pleasant flavoring  SAINT LAURENT, Quebec, Dec.
Sign-up for IntelGenx and RedHill Biopharma Announce Acceptance for Review of European Marketing Application for RIZAPORT(TM) for Migraines investment picks
The German Federal Institute for Drugs and Medical Devices (BfArM) has validated the European Marketing Authorization Application submitted for RIZAPORT ™ (RHB-103) and initiated its formal review of the application on November 25, 2014 RedHill and IntelGenx continue to work with the FDA to resolve the remaining Chemistry, Manufacturing and Controls (CMC) issues and secure a compliant source of the raw material, in order to advance potential FDA approval of the U.S. New Drug Application submitted by the companies RIZAPORT ™ oral thin film formulation of rizatriptan for acute migraines presents a potentially attractive therapeutic alternative for many migraine patients, including those suffering from migraine-related nausea, due to its convenient dosing, lack of need for water intake and pleasant flavoring TEL-AVIV, Israel, Dec.
Sign-up for RedHill Biopharma and IntelGenx Announce Acceptance for Review of European Marketing Application for RIZAPORT(TM) for Migraines investment picks
F5 Networks (NASDAQ: FFIV ) today announced the results of its 2015 State of Application Delivery survey.
Sign-up for F5 Networks Releases 2015 ‘State of Application Delivery’ Customer Survey Results investment picks
F5 Networks (NASDAQ: FFIV ) today announced new hybrid service capabilities to help organizations scale IT resources across dynamic cloud and data center deployments.
Sign-up for F5 Announces Silverline for Hybrid Application Delivery Services investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Research Applications
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Antibodies  |  Next: Research Areas